MiMedx Group, Inc.

MDXG

NASDAQ

Healthcare

Biotechnology

Marietta, GA, US837 employeesmimedx.com

$3.92

-0.03(-0.8%)

52W $3.81 – $7.96

AI-generated

MiMedx Group, Inc.

Revenue breakdown: Wound (65.5%), Surgical (34.5%).

$582MMkt Cap

$421MRev TTM

$49MNI TTM

12.9xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 24, 2026

10-K for FY2025 was filed on 2026-02-25. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Financial Results

Feb 24, 2026

of this report on Form 8-K. Item 7.01 Regulation FD On February 25, 2026 at 4:30 PM Eastern Daylight Time, the Company intends to host a conference call and web

View filing →

Regulation FD

Jan 11, 2026

Regulation FD Disclosure. MiMedx Group, Inc. (the “Company”) updated its investor presentation on January 12, 2026. A copy of the presentation materials is furn

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Wound65.5%($713M)

Surgical34.5%($376M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
DNTHDianthus Therapeutics, In...	$86.51	+2.31%	$3.3B	—
SNDXSyndax Pharmaceuticals, I...	$25.08	+5.04%	$2.2B	-7.3
NKTRNektar Therapeutics	$77.01	+1.72%	$1.6B	-9.2
INVAInnoviva, Inc.	$23.02	-1.64%	$1.5B	6.0
RAPPRapport Therapeutics, Inc...	$33.69	+6.36%	$1.2B	-11.8
TSHATaysha Gene Therapies, In...	$4.38	+1.74%	$1.1B	-13.3
CVACCVAC	$4.66	+0.00%	$1.0B	—
INBXInhibrx Biosciences, Inc.	$63.59	-5.17%	$929M	-7.1

Company Profile

CIK0001376339

ISINUS6024961012

CUSIP602496101

Phone770 651 9100

Address1775 West Oak Commons Court, NE, Marietta, GA, 30062, US

SEC EDGAR